SIRT3 Opposes Reprogramming of Cancer Cell Metabolism through HIF1α Destabilization
Lydia W.S. Finley(Harvard University), Arkaitz Carracedo(Beth Israel Deaconess Medical Center), Jaewon J. Lee(Harvard University), Amanda Souza(Broad Institute), Ainara Egia(Beth Israel Deaconess Medical Center), Jiangwen Zhang(Harvard University), Julie Teruya‐Feldstein(Memorial Sloan Kettering Cancer Center), Paula I. Moreira(University of Coimbra), Sandra M. Cardoso(University of Coimbra), Clary B. Clish(Broad Institute), Pier Paolo Pandolfi(Beth Israel Deaconess Medical Center), Marcia C. Haigis(Harvard University)
Cited by 781Open Access
Abstract
Related Papers
[37] Carbonyl assays for determination of oxidatively modified proteins
Rodney L. Levine, Joy Williams, Earl P. Stadtman et al.|Methods in enzymology on CD-ROM/Methods in enzymology|1994|2.7k